Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Share this story

Comments

“I love my life, even with Parkinson’s disease”

How DBS helped Inge Carstensen learn to live with Parkinson's

9 steps to a stress-free life with Parkinson’s

How to improve your quality of life in 9 easy steps

The road to Copenhagen: The UK Parkinson’s Football Team

We talk to team captain Charlie Appleyard

Scotland sees soaring Parkinson’s rate

The number of drugs being prescribed for people living with Parkinson’s in Scotland, UK, has increased by more than a quarter. National Health Service (NHS) figures, published by the Scottish Conservative party, show that the number of items being dispensed for the condition have leapt by 28% – from 260,355 in 2010 to 333,167 in 2019. The sharp rise is thought to be a consequence of Scotland’s ageing population and has prompted calls from bodies, including Parkinson’s UK, for government action to ensure the NHS can cope with the increasing number of Parkinson’s cases. Annie Macleod, director of Parkinson’s UK Scotland, said: “Over the next decade we expect to see numbers increase by a fifth.” She added that reasons for such a spike could include “growing numbers of people living with more complex Parkinson’s, or changes to the ways that specialists are managing Parkinson’s”.

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

More than a quarter of people living with Parkinson’s were initially misdiagnosed, according to new research from charity Parkinson’s UK. As part of the study, 2,000 people with Parkinson’s were asked a series of questions about their diagnosis. According to results, 26% of the participants were originally told they did not have Parkinson’s – with almost half of them being treated for a different condition. The poll also found that women were more likely to be misdiagnosed than men. Katie Goates, professional engagement manager at Parkinson’s UK, said: “One of the biggest challenges for Parkinson’s research is that there is no definitive test for Parkinson’s, and as a result we’ve heard of people being misdiagnosed with anything from a frozen shoulder or anxiety to a stroke. “Our survey has shown that because of this people are being left in limbo and seeing their health deteriorate, which is unacceptable.”

Queen Elizabeth II honours UK university for Parkinson’s research

A neuroscience research centre at the University of Sheffield, UK, has been recognised by Queen Elizabeth II for improving the lives of patients living with neurodegenerative conditions, including Parkinson’s. The Sheffield Institute for Translational Neuroscience, which is based at the university, uses emerging developments in neuroscience to create innovative new approaches to treating brain conditions. The prestigious Queen’s Anniversary Prize was awarded at St James’s Palace, London. The institute was commended for its development of Parkinson’s drug discovery programmes. The honour is awarded to UK universities who exhibit groundbreaking and innovative approaches to research – with beneficial results at local, national and global levels. Professor Koen Lamberts, president and vice-chancellor for the University of Sheffield, said: “As well as making life-changing discoveries today, The Sheffield Institute for Translational Neuroscience is nurturing the next generation of talented neuroscience students, whose research will lead to pioneering treatments for those living with neurological…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

sponsored article

Perspectives

“I love my life, even with Parkinson’s disease”

Health & Fitness

9 steps to a stress-free life with Parkinson’s

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Queen Elizabeth II honours UK university for Parkinson’s research

{title}

Subscribe

Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

sponsored article

Perspectives

“I love my life, even with Parkinson’s disease”

Health & Fitness

9 steps to a stress-free life with Parkinson’s

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Queen Elizabeth II honours UK university for Parkinson’s research

{title}

Subscribe

Sign in